PERTH, Western Australia & CAMBRIDGE, U.K.--(BUSINESS WIRE)--Avita Medical Ltd. (ASX: AVH), the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
